135 related articles for article (PubMed ID: 21469123)
1. Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B example.
Rosado MM; Scarsella M; Pandolfi E; Cascioli S; Giorda E; Chionne P; Madonne E; Gesualdo F; Romano M; Ausiello CM; Rapicetta M; Zanetti AR; Tozzi A; Carsetti R
Eur J Immunol; 2011 Jun; 41(6):1800-8. PubMed ID: 21469123
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level.
Carollo M; Palazzo R; Bianco M; Pandolfi E; Chionne P; Fedele G; Tozzi AE; Carsetti R; Romanò L; Ausiello CM
Vaccine; 2013 Jan; 31(3):506-13. PubMed ID: 23174200
[TBL] [Abstract][Full Text] [Related]
4. Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy.
Zanetti A; Parlato A; Romanò L; Desole MG; Ferrera G; Giurdanella F; Zuliani M; Richard P; Thomas S; Fiquet A
Vaccine; 2012 Aug; 30(39):5770-5. PubMed ID: 22789511
[TBL] [Abstract][Full Text] [Related]
5. Humoral and B-cell memory responses in children five years after pertussis acellular vaccine priming.
Carollo M; Pandolfi E; Tozzi AE; Buisman AM; Mascart F; Ausiello CM
Vaccine; 2014 Apr; 32(18):2093-9. PubMed ID: 24556506
[TBL] [Abstract][Full Text] [Related]
6. Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants.
Tregnaghi M; Zambrano B; Santos-Lima E
Pediatr Infect Dis J; 2012 Jan; 31(1):e24-30. PubMed ID: 22157567
[TBL] [Abstract][Full Text] [Related]
7. Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy.
Zanetti A; Desole MG; Romanò L; d'Alessandro A; Conversano M; Ferrera G; Panico MG; Tomasi A; Zoppi G; Zuliani M; Thomas S; Soubeyrand B; Eymin C; Lockhart S
Vaccine; 2017 Jul; 35(32):4034-4040. PubMed ID: 28624307
[TBL] [Abstract][Full Text] [Related]
8. Booster hepatitis B vaccination not necessary for long-term protection in children immunised with hexavalent vaccines.
Romanò L; Zanetti AR
J Prev Med Hyg; 2011 Jun; 52(2):45-6. PubMed ID: 21842704
[No Abstract] [Full Text] [Related]
9. Loss of antibodies, but not of protection.
Wenzel JJ; Jilg W
Lancet Infect Dis; 2010 Nov; 10(11):738-9. PubMed ID: 21029981
[No Abstract] [Full Text] [Related]
10. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses.
Heininger U; ; ; Sänger R; Jacquet JM; Schuerman L
Vaccine; 2007 Jan; 25(6):1055-63. PubMed ID: 17049692
[TBL] [Abstract][Full Text] [Related]
11. A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines.
Giambi C; Bella A; Barale A; Montù D; Marchisio M; Oddone M; Zito S; Rapicetta M; Chionne P; Madonna E; Ciofi degli Atti ML
BMC Infect Dis; 2008 Jul; 8():100. PubMed ID: 18662386
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine.
Gimenez-Sanchez F; Kieninger DM; Kueper K; Martinon-Torres F; Bernaola E; Diez-Domingo J; Steul K; Juergens C; Gurtman A; Giardina P; Liang JZ; Gruber WC; Emini EA; Scott DA;
Vaccine; 2011 Aug; 29(35):6042-8. PubMed ID: 21704105
[TBL] [Abstract][Full Text] [Related]
13. Immune memory and immune response in children from Bulgaria 5-15 years after primary hepatitis B vaccination.
Teoharov P; Kevorkyan A; Petrova N; Baltadzhiev I; Van Damme P
Pediatr Infect Dis J; 2013 Jan; 32(1):51-3. PubMed ID: 22914584
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study.
Halperin SA; McDonald J; Samson L; Danzig L; Santos G; Izu A; Smith B; MacDonald N
Clin Invest Med; 2002 Dec; 25(6):243-51. PubMed ID: 12516995
[TBL] [Abstract][Full Text] [Related]
15. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
[TBL] [Abstract][Full Text] [Related]
16. Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity.
Ciarlet M; He S; Lai S; Petrecz M; Yuan G; Liu GF; Mikviman E; Heaton PM; Panzer F; Rose T; Koller DY; Van Damme P; Schödel F
Pediatr Infect Dis J; 2009 Mar; 28(3):177-81. PubMed ID: 19209092
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.
Thisyakorn U; Pancharoen C; Chuenkitmongkol S; Ortiz E
Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):282-94. PubMed ID: 19323013
[TBL] [Abstract][Full Text] [Related]
19. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]